Ad is loading...
MNKD
Price
$6.80
Change
-$0.22 (-3.13%)
Updated
Nov 15 closing price
106 days until earnings call
OTLC
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
Earnings call today
Ad is loading...

MNKD vs OTLC

Header iconMNKD vs OTLC Comparison
Open Charts MNKD vs OTLCBanner chart's image
MannKind
Price$6.80
Change-$0.22 (-3.13%)
Volume$5.22M
CapitalizationN/A
Oncotelic Therapeutics
Price$0.03
Change-$0.00 (-0.00%)
Volume$154.46K
CapitalizationN/A
MNKD vs OTLC Comparison Chart
Loading...
MNKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MNKD vs. OTLC commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNKD is a Sell and OTLC is a Buy.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (MNKD: $6.80 vs. OTLC: $0.03)
Brand notoriety: MNKD and OTLC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNKD: 226% vs. OTLC: 41%
Market capitalization -- MNKD: $1.88B vs. OTLC: $12.13M
MNKD [@Biotechnology] is valued at $1.88B. OTLC’s [@Biotechnology] market capitalization is $12.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNKD’s FA Score shows that 1 FA rating(s) are green whileOTLC’s FA Score has 0 green FA rating(s).

  • MNKD’s FA Score: 1 green, 4 red.
  • OTLC’s FA Score: 0 green, 5 red.
According to our system of comparison, MNKD is a better buy in the long-term than OTLC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNKD’s TA Score shows that 2 TA indicator(s) are bullish.

  • MNKD’s TA Score: 2 bullish, 6 bearish.

Price Growth

MNKD (@Biotechnology) experienced а -7.42% price change this week, while OTLC (@Biotechnology) price change was -3.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

MNKD is expected to report earnings on Mar 04, 2025.

OTLC is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.88B) has a higher market cap than OTLC($12.1M). MNKD YTD gains are higher at: 86.813 vs. OTLC (-21.961). MNKD has higher annual earnings (EBITDA): 53.3M vs. OTLC (-659.92K). MNKD has more cash in the bank: 248M vs. OTLC (72.2K). OTLC has less debt than MNKD: OTLC (12.6M) vs MNKD (231M). MNKD has higher revenues than OTLC: MNKD (248M) vs OTLC (70K).
MNKDOTLCMNKD / OTLC
Capitalization1.88B12.1M15,496%
EBITDA53.3M-659.92K-8,077%
Gain YTD86.813-21.961-395%
P/E Ratio85.00N/A-
Revenue248M70K354,286%
Total Cash248M72.2K343,490%
Total Debt231M12.6M1,833%
FUNDAMENTALS RATINGS
MNKD vs OTLC: Fundamental Ratings
MNKD
OTLC
OUTLOOK RATING
1..100
8250
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
19100
SMR RATING
1..100
10090
PRICE GROWTH RATING
1..100
3846
P/E GROWTH RATING
1..100
8495
SEASONALITY SCORE
1..100
2843

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OTLC's Valuation (55) in the null industry is in the same range as MNKD (76) in the Biotechnology industry. This means that OTLC’s stock grew similarly to MNKD’s over the last 12 months.

MNKD's Profit vs Risk Rating (19) in the Biotechnology industry is significantly better than the same rating for OTLC (100) in the null industry. This means that MNKD’s stock grew significantly faster than OTLC’s over the last 12 months.

OTLC's SMR Rating (90) in the null industry is in the same range as MNKD (100) in the Biotechnology industry. This means that OTLC’s stock grew similarly to MNKD’s over the last 12 months.

MNKD's Price Growth Rating (38) in the Biotechnology industry is in the same range as OTLC (46) in the null industry. This means that MNKD’s stock grew similarly to OTLC’s over the last 12 months.

MNKD's P/E Growth Rating (84) in the Biotechnology industry is in the same range as OTLC (95) in the null industry. This means that MNKD’s stock grew similarly to OTLC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MNKD
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
68%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Ad is loading...
MNKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPLT6.630.16
+2.41%
Katapult Holdings
AWI153.280.07
+0.05%
Armstrong World Industries
MSI489.00-4.70
-0.95%
Motorola Solutions
MLNK22.02-0.68
-3.00%
MeridianLink
RXT2.42-0.24
-9.02%
Rackspace Technology

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with QSI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
-3.13%
QSI - MNKD
44%
Loosely correlated
-5.77%
NTLA - MNKD
44%
Loosely correlated
-7.61%
VCYT - MNKD
44%
Loosely correlated
-2.97%
BEAM - MNKD
43%
Loosely correlated
-8.59%
PGEN - MNKD
42%
Loosely correlated
-7.11%
More

OTLC and

Correlation & Price change

A.I.dvisor tells us that OTLC and TENX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and TENX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
+7.57%
TENX - OTLC
23%
Poorly correlated
-1.42%
MNKD - OTLC
22%
Poorly correlated
-3.13%
IMTX - OTLC
21%
Poorly correlated
-4.22%
MMIRF - OTLC
15%
Poorly correlated
N/A
IUGNF - OTLC
13%
Poorly correlated
-6.25%
More